Neoantigens Elicit Protumorigenic Immune Responses in Pancreatic Cancer
- PMID: 32220924
- DOI: 10.1158/2159-8290.CD-RW2020-047
Neoantigens Elicit Protumorigenic Immune Responses in Pancreatic Cancer
Abstract
Neoantigen-expressing pancreatic cancers had hastened progression and poor immunotherapy response.
©2020 American Association for Cancer Research.
Comment on
-
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer.Cancer Cell. 2020 Mar 16;37(3):289-307.e9. doi: 10.1016/j.ccell.2020.02.008. Cancer Cell. 2020. PMID: 32183949 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
